Option Care Health, Inc. $OPCH Shares Bought by Fort Washington Investment Advisors Inc. OH

Fort Washington Investment Advisors Inc. OH boosted its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 5.1% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 1,421,567 shares of the company’s stock after acquiring an additional 68,572 shares during the quarter. Fort Washington Investment Advisors Inc. OH’s holdings in Option Care Health were worth $31,971,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of OPCH. Harbor Investment Advisory LLC purchased a new stake in Option Care Health during the second quarter worth $48,000. Nykredit A S bought a new stake in Option Care Health during the 2nd quarter valued at $56,000. Public Employees Retirement System of Ohio bought a new stake in Option Care Health during the 2nd quarter valued at $66,000. KBC Group NV boosted its position in Option Care Health by 22.1% during the 1st quarter. KBC Group NV now owns 5,453 shares of the company’s stock valued at $147,000 after acquiring an additional 988 shares in the last quarter. Finally, Summitry LLC purchased a new position in shares of Option Care Health in the 1st quarter valued at $200,000. Institutional investors own 98.05% of the company’s stock.

Option Care Health Stock Up 0.3%

Shares of Option Care Health stock opened at $31.22 on Friday. The firm’s 50 day moving average price is $24.85 and its 200-day moving average price is $23.69. The company has a quick ratio of 0.98, a current ratio of 1.47 and a debt-to-equity ratio of 0.91. Option Care Health, Inc. has a 52-week low of $18.01 and a 52-week high of $36.80. The company has a market cap of $4.68 billion, a P/E ratio of 19.70, a PEG ratio of 1.89 and a beta of 0.58.

Option Care Health (NASDAQ:OPCH) last posted its quarterly earnings data on Wednesday, July 29th. The company reported $0.45 EPS for the quarter, topping the consensus estimate of $0.43 by $0.02. Option Care Health had a net margin of 3.68% and a return on equity of 18.74%. The firm had revenue of $1.44 billion during the quarter, compared to analyst estimates of $1.42 billion. During the same quarter in the previous year, the business posted $0.41 EPS. Option Care Health’s revenue was up 1.9% on a year-over-year basis. Option Care Health has set its FY 2026 guidance at 1.850-1.920 EPS. On average, sell-side analysts predict that Option Care Health, Inc. will post 1.70 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on OPCH. Jefferies Financial Group downgraded Option Care Health from a “buy” rating to a “hold” rating and lifted their price target for the company from $28.00 to $32.05 in a report on Tuesday, October 6th. Morgan Stanley set a $32.05 price objective on Option Care Health in a research note on Monday. Citizens Jmp cut Option Care Health from a “market outperform” rating to a “hold” rating in a research note on Wednesday, October 7th. Weiss Ratings raised Option Care Health from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday, September 11th. Finally, William Blair lowered Option Care Health from an “outperform” rating to a “market perform” rating in a research note on Tuesday, October 6th. Two research analysts have rated the stock with a Buy rating and fourteen have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Option Care Health has an average rating of “Hold” and an average target price of $29.48.

Option Care Health Profile

Option Care Health, Inc (NASDAQ: OPCH) is a provider of home and alternate-site infusion services in the United States. The company works with patients, physicians, hospitals, health plans and pharmaceutical manufacturers to deliver and manage infusion therapy outside traditional hospital settings, including in patients’ homes, ambulatory infusion suites and other community-based locations.

Its services include the provision and administration of specialty medications and other infusion therapies for conditions such as infections, immune disorders, chronic diseases and nutritional deficiencies.